Proto Labs (NYSE:PRLB) Releases Q3 2026 Earnings Guidance

Proto Labs (NYSE:PRLB) issued an update on its third quarter 2026 earnings guidance on Friday morning. The company provided earnings per share guidance of 0.560-0.640 for the period, compared to the consensus earnings per share estimate of 0.480. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $145.9 million.

Proto Labs Trading Up 5.5%

Shares of Proto Labs stock opened at $75.26 on Friday. The business’s fifty day moving average price is $76.94 and its 200 day moving average price is $66.64. Proto Labs has a twelve month low of $40.84 and a twelve month high of $83.15. The stock has a market capitalization of $1.79 billion, a P/E ratio of 71.00 and a beta of 1.38.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.54 by $0.06. The company had revenue of $149.34 million during the quarter, compared to analyst estimates of $144.53 million. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, sell-side analysts predict that Proto Labs will post 1.37 EPS for the current year.

Wall Street Analyst Weigh In

PRLB has been the topic of several research reports. Zacks Research lowered shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a report on Friday, July 3rd. Weiss Ratings raised shares of Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, July 17th. Benchmark lifted their price target on shares of Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $65.33.

Insiders Place Their Bets

In other news, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total value of $1,113,924.70. Following the transaction, the insider directly owned 18,683 shares in the company, valued at approximately $1,298,281.67. This trade represents a 46.18% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the completion of the transaction, the director owned 32,505 shares in the company, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 25,663 shares of company stock valued at $1,804,727. 1.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Proto Labs

Institutional investors and hedge funds have recently bought and sold shares of the business. Disciplined Growth Investors Inc. MN lifted its holdings in shares of Proto Labs by 1.9% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 2,722,011 shares of the industrial products company’s stock worth $108,989,000 after purchasing an additional 51,293 shares during the last quarter. Rubric Capital Management LP increased its holdings in shares of Proto Labs by 8.6% in the 3rd quarter. Rubric Capital Management LP now owns 1,123,338 shares of the industrial products company’s stock worth $56,201,000 after acquiring an additional 89,167 shares during the period. American Capital Management Inc. increased its holdings in shares of Proto Labs by 126.0% in the 4th quarter. American Capital Management Inc. now owns 631,311 shares of the industrial products company’s stock worth $31,938,000 after acquiring an additional 352,015 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in Proto Labs by 3.0% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 460,618 shares of the industrial products company’s stock valued at $23,045,000 after purchasing an additional 13,488 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Proto Labs by 9.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 363,013 shares of the industrial products company’s stock valued at $18,365,000 after purchasing an additional 31,585 shares during the last quarter. Institutional investors and hedge funds own 84.54% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.